Consumer Protection Act | Pharmaceutical Jurisprudence | GPAT Mock Test

Welcome to this specialized mock test on the Consumer Protection Act, 2019, tailored for GPAT aspirants. This quiz focuses on the crucial sub-topic of consumer rights and remedies within the pharmaceutical sector. You will be tested on your understanding of key definitions, consumer rights, the structure of redressal agencies, and specific scenarios a pharmacist might encounter. This test comprises 25 multiple-choice questions designed to mirror the GPAT examination level, helping you assess and strengthen your knowledge in Pharmaceutical Jurisprudence. After submitting your answers, you’ll receive your score and see the correct answers highlighted. You can also download a PDF of all questions with their correct answers for future revision. Best of luck!

1. Under the Consumer Protection Act, 2019, who among the following is considered a ‘consumer’ in a pharmaceutical context?

2. Which of the following would be considered a ‘defect’ in a drug as per the Consumer Protection Act?

3. A pharmacist dispensing a prescription medicine without providing proper counseling on its usage and side effects can be held liable for:

4. The sale of expired medicines by a pharmacy primarily violates which consumer right?

5. A chemist selling a medicine above the Maximum Retail Price (MRP) infringes upon the consumer’s:

6. What is the pecuniary jurisdiction of a District Consumer Disputes Redressal Commission under the CPA, 2019?

7. A consumer wants to file a complaint regarding a defective batch of medicines valued at ₹1.5 crore. Which authority should they approach?

8. The National Consumer Disputes Redressal Commission has jurisdiction for claims where the value of goods or services paid as consideration exceeds:

9. What is the time limit for filing a complaint from the date on which the cause of action has arisen?

10. Who CANNOT file a complaint under the Consumer Protection Act?

11. A pharmacist substituting a prescribed brand of medicine with another brand (generic) containing the same salt, after informing the patient, is considered:

12. A consumer suffers a severe allergic reaction due to a wrongly dispensed medicine. What remedy can the Consumer Commission NOT grant?

13. The Central Consumer Protection Authority (CCPA) was established under CPA, 2019 to primarily:

14. A pharmaceutical company advertises a supplement as a “guaranteed cure for diabetes.” This act can be penalized by the CCPA as a:

15. The concept of ‘Product Liability’ under CPA, 2019 holds whom responsible for harm caused by a defective medical device?

16. A consumer files a complaint for compensation of ₹75 lakhs due to a faulty glucometer causing incorrect readings and subsequent harm. The complaint should be filed with the:

17. A pharmacist refuses to issue a proper bill/invoice for the medicines purchased. This action directly curtails the consumer’s:

18. The provision for mediation as an alternate dispute resolution mechanism was introduced in which Act?

19. Which of the following is an example of an ‘unfair trade practice’ by a pharmacy?

20. An appeal against an order passed by the District Commission can be filed in the State Commission within:

21. The Consumer Protection Act, 2019, replaced the:

22. Which of the six consumer rights under the CPA is most relevant when a patient is not informed about the potential side effects of a potent drug?

23. A pharmacy claims its in-house multivitamin “is approved by the WHO” when it is not. This constitutes:

24. What is the limitation period for filing an appeal to the National Commission against an order of the State Commission?

25. A pharmacist forcing a consumer to buy a full strip of tablets when the prescription is only for a few tablets can be considered a form of: